, Tracking Stock Market Picks
Enter Symbol:
Ariad Pharmaceuticals, Inc. (ARIA) [hlAlert]

down 73.20 %

Ariad Pharmaceuticals, Inc. (ARIA) rated Sell by Merriman

Posted on: Friday,  Jul 31, 2009  8:25 AM ET by Merriman

Merriman rated Sell Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) on 07/31/2009, when the stock price was $1.87. Since
then, Ariad Pharmaceuticals, Inc. has gained 273.26% as of 01/19/2016's recent price of $6.98.
If you would have followed this Merriman's recommendation on ARIA, you would have lost 73.2% of your investment in 2363 days.

Ariad Pharmaceuticals is engaged in the discovery and development of novel pharmaceuticals based on intracellular signaling technology. The Company has established highly integrated capabilities in functional genomics, molecular cell biology, structure based drug design, combinatorial chemistry and pharmacology. The company is developing small-molecule drugs that block signal transduction pathways in cells responsible for osteoporosis, and immune and inflammatory diseases.

Merriman provides advanced tools for acquiring such information. These tools integrate a combination of cycles, geocosmic signatures and trend analysis patterns in assisting the serious investor in their interpretation of the various financial markets and the general economy. In today's fast paced and seemingly chaotic marketplace, you need the edge that only a broader analysis of human activity can provide.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/31/2009 8:25 AM Sell
as of 12/31/2009
1 Week down  -209.17 %
1 Month down  -183.18 %
3 Months down  -189.59 %
1 YTD down  -242.24 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy